JP1302

Overview

JP1302 is a potent, selective, high affinity antagonist of the α 2C -adrenoceptor , with a K b of 16 nM and a K i of 28 nM for the human α 2C -receptor. JP1302 shows antidepressant and antipsychotic-like effects. JP1302 can be used for neuropsychiatric disorders and renal dysfunction research.

Application

Products | Products > Disease Areas > Alzheimer's Disease | Products > Disease Areas > Hypertension | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Cardiovascular Disease | Products > Disease Areas > Depression | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Adrenergic Receptor

Product Information

• Catalog No.: HY-103213A
• CAS No.: 80259-18-3
• Molecular Formula: C24H24N4
• Molecular Weight: 368.47
• Purity: 98.68%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Availability: In-stock

Source

Original product source